Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism

Life Sciences

Volumn 83, Issue 3-4, 2008, Pages 96-102

  Gunasingh, Masilamoni J ^a   Philip, Jesudason E ^a   Ashok, Ben S ^b   Kirubagaran, R ^c   Jebaraj, W Charles E ^b   Davis, G Dicky John ^b   Vignesh, S ^a   Dhandayuthapani, S ^a   Jayakumar, R ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c NATIONAL INSTITUTE OF OCEANOGRAPHY   (India)

Author keywords

A amyloid; Biogenic amines; Enzymic and nonenzymic antioxidants; GFAP; Melatonin; NF B; ROS

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; BIOGENIC AMINE; CATALASE; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HOMOVANILLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SEROTONIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN PROTECTION; BRAIN TOXICITY; CATABOLISM; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER CELL; LYMPHOCYTE; MALE; MOUSE; NEOCORTEX; NONHUMAN; NORADRENERGIC SYSTEM; OXIDATIVE STRESS; SEROTONINERGIC SYSTEM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; ASTROCYTES; BIOGENIC AMINES; BRAIN; CATALASE; GLUTATHIONE; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER; LYMPHOCYTES; MALE; MELATONIN; MICE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

MUS;

EID: 46449090217     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.05.011     Document Type: Article

References (68)

1. Abe K., and Saito H. Menadione toxicity in cultured rat cortical astrocytes. Japan Journal of Pharmacology 72 (1996) 299-306
2. Antolin I., Mayo J.C., Sainz R.M., del Brio Mde L., Herrera F., Martin V., and Rodriguez C. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Research 943 (2002) 163-173
3. Baydas G., and Tuzcu M. Protective effects of melatonin against ethanol-induced reactive gliosis in hippocampus and cortex of young and aged rats. Experimental Neurology 194 (2005) 175-181
4. Beers Jr. R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Journal of Biological Chemistry 195 1 (1952) 133-140
5. Behl C. Vitamin E and other antioxidants in neuroprotection. International Journal of Vitamin and Nutrition Research 69 (1999) 213-219
6. Behl C., Davis J., Cole G.M., and Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochemical and Biophysical Research Communications 186 (1992) 944-950
7. Bell K.F., and Claudio Cuello A. Altered synaptic function in Alzheimer's disease. European Journal of Pharmacolology 545 (2006) 11-21
8. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. Journal of Biological Chemistry 267 (1992) 546-554
9. Cathcart R., Schwiers E., and Ames B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Analytical Biochemistry 134 (1983) 111-116
10. Clapp-Lilly K.L., Smith M.A., Perry G., Harris P.L., Zhu X., and Duffy L.K. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. NeuroReport 12 (2001) 1277-1280
11. Dairam A., Muller A.C., and Daya S. Non-steroidal anti-inflammatory agents, tolmetin and sulindac attenuate quinolinic acid (QA)-induced oxidative stress in primary hippocampal neurons and reduce QA-induced spatial reference memory deficits in male Wistar rats. Life Sciences 80 (2007) 1431-1438
12. Dyon-Laurent C., Herve A., and Sara S.J. Noradrenergic hyperactivity in hippocampus after partial denervation: pharmacological, behavioral, and electrophysiological studies. Experimental Brain Research 99 (1994) 259-266
13. Gabryel B., and Trzeciak H.I. Role of astrocytes in pathogenesis of ischemic brain injury. Neurotoxicity Research 3 (2001) 205-221
14. Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience 66 (1995) 781-792
15. Grima G., Benz B., Parpura V., Cuenod M., and Do K.Q. Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophrenia Research 62 (2003) 213-224
16. Harkany T., O'Mahony S., Keijser J., Kelly J.P., Konya C., Borostyankoi Z.A., Gorcs T.J., Zarandi M., Penke B., Leonard B.E., and Luiten P.G. Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiology of Disease 8 (2001) 667-678
17. Harper J.D., Lieber C.M., and Lansbury Jr. P.T. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chemistry and Biology 4 (1997) 951-959
18. Harper J.D., Wong S.S., Lieber C.M., and Lansbury P.T. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chemistry and Biology 4 (1997) 119-125
19. Hirrlinger J., Schulz J.B., and Dringen R. Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. Journal of Neuroscience Research 69 3 (2002) 318-326
20. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., and Bush A.I. Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. Journal of Biological Chemistry 274 (1999) 37111-37116
21. Huang H.M., Ou H.C., and Hsieh S.J. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sciences 66 (2000) 1879-1892
22. Jesudason E.P., Masilamoni J.G., Kirubagaran R., Davis G.D., and Jayakumar R. The protective role of DL-alpha-lipoic acid in biogenic amines catabolism triggered by Abeta amyloid vaccination in mice. Brain Research Bulletin 65 (2005) 361-367
23. Jesudason E.P., Baben B., Ashok B.S., Masilamoni J.G., Kirubagaran R., Jebaraj W.C., and Jayakumar R. Anti-inflammatory effect of melatonin on A beta vaccination in mice. Molecular and Cellular Biochemistry 298 (2007) 69-81
24. Johnstone M., Gearing A.J., and Miller K.M. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. Journal of Neuroimmunology 93 (1999) 182-193
25. Kaltschmidt B., Heinrich M., and Kaltschmidt C. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Medicine 2 (2002) 299-309
26. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., and Mattson M.P. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proceedings of the National Academy of Sciences of United States of America 93 (1996) 6753-6758
27. Kraus B., Wolff H., Heilmann J., and Elstner E.F. Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sciences 81 (2007) 884-894
28. Lahiri D.K., Chen D., Ge Y.W., Bondy S.C., and Sharman E.H. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. Journal of Pineal Research 36 (2004) 224-231
29. Lahiri D.K., Chen D., Lahiri P., Rogers J.T., Greig N.H., and Bondy S. Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders. Annals of the New York Academy of Sciences 1035 (2004) 216-230
30. Lahiri D.K., Chen D.M., Lahiri P., Bondy S., and Greig N.H. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases. Annals of the New York Academy of Sciences 1056 (2005) 430-449
31. Lehericy S., Hirsch E.C., Cervera-Pierot P., Hersh L.B., Bakchine S., Piette F., Duyckaerts C., Hauw J.J., Javoy-Agid F., and Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. The Journal of Comparative Neurology 330 (1993) 15-31
32. Liu R., McAllister C., Lyubchenko Y., and Sierks M.R. Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation. Journal of neuroscience research 75 (2004) 162-171
33. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
34. Masilamoni J.G., Jesudason E.P., Bharathi S.N., and Jayakumar R. The protective effect of alpha-crystallin against acute inflammation in mice. Biochimica et Biophysica Acta 1740 (2005) 411-420
35. Masilamoni J.G., Jesudason E.P., Jesudoss K.S., Murali J., Paul S.F., and Jayakumar R. Role of fibrillar Abeta25-35 in the inflammation induced rat model with respect to oxidative vulnerability. Free Radical Research 39 (2005) 603-612
36. Masilamoni J.G., Jesudason E.P., Baben B., Jebaraj C.E., Dhandayuthapani S., and Jayakumar R. Molecular chaperone alpha-crystallin prevents detrimental effects of neuroinflammation. Biochimica et Biophysica Acta 1762 (2006) 284-293
37. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., and Di Monte D.A. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. Journal of Neurochemistry 93 (2005) 1030-1037
38. Minghetti L. Role of inflammation in neurodegenerative diseases. Current Opinion in Neurology 18 (2005) 315-321
39. Misra H.P., and Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 247 (1972) 3170-3175
40. Moen T., Nousiainen H., Bratlie A., Solheim B.G., and Thorsby E. Detection of HLA-D region products by primed lymphocyte typing (PLT). Human Immunology 2 (1981) 287-294
41. Monji A., Utsumi H., Ueda T., Imoto T., Yoshida I., Hashioka S., Tashiro K., and Tashiro N. Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides. Life Sciences 70 (2002) 833-841
42. Moron M.S., Depierre J.W., and Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 582 (1979) 67-78
43. Nielsen E.H., Nybo M., and Svehag S.E. Electron microscopy of prefibrillar structures and amyloid fibrils. Methods in Enzymology 309 (1999) 491-496
44. Olariu A., Tran M.H., Yamada K., Mizuno M., Hefco V., and Nabeshima T. Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. Journal of Neural Transmission 108 (2001) 1065-1079
45. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., and Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. The Journal of Neuroscience 17 (1997) 1683-1690
46. Pizzi M., and Spano P. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. European Journal of Pharmacology 545 (2006) 22-28
47. Poduslo J.F., Curran G.L., Sanyal B., and Selkoe D.J. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier. Neurobiology of Disease 6 (1999) 190-199
48. Poeggeler B., Miravalle L., Zagorski M.G., Wisniewski T., Chyan Y.J., Zhang Y., Shao H., Bryant-Thomas T., Vidal R., Frangione B., Ghiso J., and Pappolla M.A. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. Biochemistry 40 (2001) 14995-15001
49. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., and Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. The Journal of Neuroscience 21 (2001) 4183-4187
50. Reiter R., Tang L., Garcia J.J., and Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sciences 60 (1997) 2255-2271
51. Segura-Aguilar J., and Lind C. On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine: prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase. Chemico-Biological Interaction 72 (1989) 309-324
52. Sharman E.H., Bondy S.C., Sharman K.G., Lahiri D., Cotman C.W., and Perreau V.M. Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochemistry international 50 (2007) 336-344
53. Skribanek Z., Balaspiri L., and Mak M. Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry. Journal of Mass Spectrometry 36 (2001) 1226-1229
54. Spooner E.T., Desai R.V., Mori C., Leverone J.F., and Lemere C.A. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol. Vaccine 21 (2002) 290-297
55. Steckler T., and Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behavioral Brain Research 67 (1995) 165-199
56. Szot P., Leverenz J.B., Peskind E.R., Kiyasu E., Rohde K., Miller M.A., and Raskind M.A. Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease. Brain Research Molecular Brain Research 84 (2000) 135-140
57. Tang F., Nag S., Shiu S.Y., and Pang S.F. The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40. Life Sciences 71 (2002) 2625-2631
58. Uberti D., Bianchi I., Olivari L., Ferrari-Toninelli G., Canonico P., and Memo M. Pramipexole prevents neurotoxicity induced by oligomers of beta-amyloid. European Journal of Pharmacology 569 (2007) 194-196
59. Urata Y., Honma S., Goto S., Todoroki S., Iida T., Cho S., Honma K., and Kondo T. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radical Biology and Medicine 27 (1999) 838-847
60. Vanderwolf C.H., and Baker G.B. The role of brain noradrenaline in cortical activation and behavior: a study of lesions of the locus coeruleus, medial thalamus and hippocampus-neocortex and of muscarinic blockade in the rat. Behavioral Brain Research 78 (1996) 225-234
61. von Bernhardi R., and Eugenin J. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Research 1025 (2004) 186-193
62. Wallace M.N., Geddes J.G., Farquhar D.A., and Masson M.R. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Experimental Neurology 144 (1997) 266-272
63. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biological Chemistry 272 (1997) 22364-22372
64. Wang S.Y., Wang H.H., Chi C.W., Chen C.F., and Liao J.F. Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice. European Journal of Pharmacology 506 (2004) 55-61
65. Wise K.C., Manna S.K., Yamauchi K., Ramesh V., Wilson B.L., Thomas R.L., Sarkar S., Kulkarni A.D., Pellis N.R., and Ramesh G.T. Activation of nuclear transcription factor-kappaB in mouse brain induced by a simulated microgravity environment. In Vitro Cellular and Developmental Biology. Animal 41 (2005) 118-123
66. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
67. Zhang N.Y., Kitagawa K., Hattori N., Nakayama Y., Xiong Z.M., Wu B., Liu B., and Inagaki C. Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid beta protein-induced degeneration of hippocampal neurons in V337M human tau-expressing mice. Life Sciences 80 (2007) 1971-1976
68. Zlokovic B.V., Ghiso J., Mackic J.B., McComb J.G., Weiss M.H., and Frangione B. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochemical and Biophysical Research Communication 197 (1993) 1034-1040